MK-7680

MK-7680 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7680, covering 2015-07-27 to 2015-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003) [Phase 1]